Horizon Investments, LLC Pfizer Inc Transaction History

Horizon Investments, LLC

$4.46 Billion
Q2 2024

A detailed history of Horizon Investments, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Horizon Investments, LLC holds 81,205 shares of PFE stock, worth $2.42 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

81,205

Previous 80,158 1.31%

Holding current value

$2.42 Million

Previous $2.22 Million 2.16%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $26,447 - $30,991	1,047 Added 1.31%	81,205 $2.27 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $1.31 Million - $1.5 Million	-50,463 Reduced 38.63%	80,158 $2.22 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $510,972 - $663,696	-19,555 Reduced 13.02%	130,621 $3.76 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $104,645 - $122,320	3,261 Added 2.22%	150,176 $4.98 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $141,951 - $164,234	-3,930 Reduced 2.61%	146,915 $5.39 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $2.36 Million - $3.07 Million	-59,933 Reduced 28.43%	150,845 $6.15 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $3,214 - $4,196	-77 Reduced 0.04%	210,778 $10.7 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $731,886 - $893,449	16,725 Added 8.62%	210,855 $9.15 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $577,669 - $684,935	-12,415 Reduced 6.01%	194,130 $10.1 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $869,067 - $1.08 Million	18,996 Added 10.13%	206,545 $10.6 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $660,624 - $979,265	15,988 Added 9.32%	187,549 $11 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $2.41 Million - $3.1 Million	61,399 Added 55.74%	171,561 $7.32 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $2.34 Million - $2.65 Million	65,225 Added 145.15%	110,162 $4.28 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $1.5 Million - $1.7 Million	44,937 New	44,937 $1.63 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $1.9 Million - $2.41 Million	-56,660 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $862,330 - $1.01 Million	-27,160 Reduced 32.4%	56,660 $2.06 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $2.14 Million - $2.6 Million	-71,119 Reduced 45.9%	83,820 $2.71 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $519,300 - $741,967	-19,212 Reduced 11.03%	154,939 $5.01 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $4.82 Million - $5.47 Million	146,310 Added 525.52%	174,151 $6.82 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $88,242 - $114,425	2,716 Added 10.81%	27,841 $991,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $2.22 Million - $2.49 Million	-60,025 Reduced 70.49%	25,125 $1.09 Million
Q1 2019 May 16, 2019	BUY	$37.5 - $41.2 $685,125 - $752,724	18,270 Added 27.32%	85,150 $3.59 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $524,769 - $598,294	13,641 Added 25.62%	66,880 $2.92 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $169,351 - $205,412	4,913 Added 10.17%	53,239 $2.33 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $825,390 - $879,949	-25,027 Reduced 34.12%	48,326 $1.74 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $487,871 - $565,998	15,289 Added 26.33%	73,353 $2.6 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $517,858 - $549,465	15,570 Added 36.64%	58,064 $1.92 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $895,592 - $950,253	-26,927 Reduced 38.79%	42,494 $1.4 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $2.15 Million - $2.37 Million	69,421	69,421 $2.29 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.

Account

Horizon Investments, LLC Pfizer Inc Transaction History